@article{59329a5e48eb4775ac6ee9654aaaf68c,
title = "Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas",
keywords = "2-hydroxyglutarate, IDH, biomarker, glioma, monitoring",
author = "Cecile Riviere-Cazaux and Lacey, {Jean M.} and Carlstrom, {Lucas P.} and Laxen, {William J.} and Amanda Munoz-Casabella and Hoplin, {Matthew D.} and Samar Ikram and Zubair, {Abdullah Bin} and Andersen, {Katherine M.} and Warrington, {Arthur E.} and Decker, {Paul A.} and Kaufmann, {Timothy J.} and Campian, {Jian L.} and Eckel-Passow, {Jeanette E.} and Kizilbash, {Sani H.} and Silvia Tortorelli and Burns, {Terry C.}",
note = "Funding Information: National Institutes of Health NINDS R61 NS122096 to TCB, TJK, JEP, PAD, SHK, AEW; National Institute of Health T32GM065841 to CRC; Mayo Clinic Center for Individualized Medicine and CCaTS award UL1TR002377 to TCB; support was also provided to TCB by Lucius and Terrie McKelvey. ",
year = "2023",
month = jan,
day = "1",
doi = "10.1093/noajnl/vdad061",
language = "English (US)",
volume = "5",
journal = "Neuro-Oncology Advances",
issn = "2632-2498",
publisher = "Oxford University Press",
number = "1",
}